NCT00359216View on ClinicalTrials.gov

The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Perennial Allergic RhinitisObstructive Sleep ApneaSleep Disorder
Interventions
DRUG

Mometasone furoate nasal spray

MFNS, 50 mcg/spray. Each subject to take 200 mcg (4 sprays) once daily in the morning.

DRUG

Placebo

Placebo nasal spray. Each subject to take 4 sprays once daily in the morning.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00359216 - The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726) | Biotech Hunter | Biotech Hunter